News Article
Riber 2010 Revenues Up 20% to €20.7 million
The firm’s order book for 2010 was €17.3 million, 6.9 times higher than end of 2009.
Riber, a manufacturer of molecular beam epitaxy (MBE) equipment, has announced €20.7 million in full-year revenues, including €13.1 million for the fourth quarter.
MBE system sales were up 10% to €11.1 million. This growth reflects the good level of sales to research
centers and the upturn in demand from industrial firms for compound semiconductors. In 2010, the firm sold 10 MBE systems ; three production systems and seven research systems. One of the systems will be delivered after 2011.
Riber says its services and accessories business has continued to develop at a strong rate, with revenues climbing to a record level of €6.5 million, representing growth of 38% in relation to 2009.
Sales of evaporation sources and cells increased by 24%, confirming the relevance of the strategy to diversify into the strong-growing markets for organic LEDs (OLED) and thin-layer solar panels for CIGS technology.
In 2010, the Riber sales in Europe amounted to 56% of which 35% went to Russia. In Asia, the firm sales were 28% and in North America 16%.
The order book does not include the major OLED effusion cell contract signed in January 2011 for several million euros.
Riber will announce its 2010 full-year earnings on March 24th, 2011 (after close of trading).